Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
Aim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III crit...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2014-07-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1086 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860237405257728 |
---|---|
author | O. V. Krapivnaya |
author_facet | O. V. Krapivnaya |
author_sort | O. V. Krapivnaya |
collection | DOAJ |
description | Aim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III criteria) were investigated. All patient underwent BFT (mean No of sessions 6,1±0,9) with rating of IBS symptoms, quality of life (by SF-36 questionnaire), parameters of anorectal manometry before the termination of BFT course.Results. According to anorectal manometry data 1-st type defecation dyssynergy (DD) was diagnosed in 28,9% of patients, dysfunction of an external anal sphincter – in 71,1%. BFT was effective in 24 (63%) patients: in 17 (62,9%) with IBS-C and in 7 (63,6%) with IBS-C and 1-st type DD. Frequency of defecations has increased from 1,1±0,1 to 4,9±0,3 per week (p<0,001), other IBS symptoms (p<0,01) have decreased. Defecation index (OR 6,5; 95% – CI 1,09–39,3) was significant prognostic factor for BFT efficacy.Conclusions. In 63% of patients with IBS-C BFT was effective. The high defecation index (> 1,2) is significant prognostic factor for BFT efficacy. |
format | Article |
id | doaj-art-db226cb14a614329a36cfc0fde428e38 |
institution | Kabale University |
issn | 1382-4376 2658-6673 |
language | Russian |
publishDate | 2014-07-01 |
publisher | Gastro LLC |
record_format | Article |
series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
spelling | doaj-art-db226cb14a614329a36cfc0fde428e382025-02-10T16:14:33ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732014-07-012411620687Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipationO. V. Krapivnaya0Non-government healthcare institution «Khabarovsk-1 Road clinical hospital, Open Society «Russian RailwaysAim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III criteria) were investigated. All patient underwent BFT (mean No of sessions 6,1±0,9) with rating of IBS symptoms, quality of life (by SF-36 questionnaire), parameters of anorectal manometry before the termination of BFT course.Results. According to anorectal manometry data 1-st type defecation dyssynergy (DD) was diagnosed in 28,9% of patients, dysfunction of an external anal sphincter – in 71,1%. BFT was effective in 24 (63%) patients: in 17 (62,9%) with IBS-C and in 7 (63,6%) with IBS-C and 1-st type DD. Frequency of defecations has increased from 1,1±0,1 to 4,9±0,3 per week (p<0,001), other IBS symptoms (p<0,01) have decreased. Defecation index (OR 6,5; 95% – CI 1,09–39,3) was significant prognostic factor for BFT efficacy.Conclusions. In 63% of patients with IBS-C BFT was effective. The high defecation index (> 1,2) is significant prognostic factor for BFT efficacy.https://www.gastro-j.ru/jour/article/view/1086irritable bowel syndromebiofeedbacktherapyanorectal manometry |
spellingShingle | O. V. Krapivnaya Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation Российский журнал гастроэнтерологии, гепатологии, колопроктологии irritable bowel syndrome biofeedbacktherapy anorectal manometry |
title | Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
title_full | Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
title_fullStr | Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
title_full_unstemmed | Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
title_short | Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
title_sort | effect of biofeedback therapy on clinical semiology quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation |
topic | irritable bowel syndrome biofeedbacktherapy anorectal manometry |
url | https://www.gastro-j.ru/jour/article/view/1086 |
work_keys_str_mv | AT ovkrapivnaya effectofbiofeedbacktherapyonclinicalsemiologyqualityoflifeandsensorimotorfunctionofanorectalareaatirritablebowelsyndromewithrefractoryconstipation |